Elizabeth Poynor, M.D., PhD, F.A.C.O.G.

Click here for full CV

Click here to listen to a radio interview with Dr. Poynor

"As a surgeon specializing in the diagnosis and treatment of complex gynecologic malignancies, I have always realized that the successful battle against a cancer hinges on utilizing the best treatment possible for a woman. As a daughter with a Father diagnosed with a lethal cancer, I have learned the lifesaving value of second opinions. When my Father was diagnosed with a lethal leukemia I flew immediately home and sat by his bedside to hear from his doctor that he was not an appropriate candidate for any treatment. That was five years ago, thanks to his second opinion and a new experimental drug.  As a physician and daughter of two parents who have successfully battled cancer, each day in my busy office, I quietly recall my role as a daughter, in order to assure that I am giving my very best recommendation for care. My expertise is in the surgical and medical management of gynecologic cancers. After maintaining a busy surgical oncology practice for ten years at Memorial Sloan-Kettering Cancer Center, I started my own surgical practice dedicated to the care of women in a compassionate and personalized setting, where medical decision making is made with the patient as the center of the team. I have an active role in resident education and in developing minimally invasive surgical approaches in the treatment of gynecologic malignancies, such as robotic surgery."

Previous Director of Translational Research Memorial Sloan Kettering Cancer Center


  • Ovarian & Primary Peritoneal Cancer
  • Uterine Cancer
  • Cervical Cancer
  • Gestational Trophoblastic Disease
  • Vaginal & Vulvar Cancer
  • Hereditary Malignancies
  • Others


Gynecologic Oncology Fellowship: Memorial Sloan Kettering Cancer Center, New York

Residency: Obstetrics & Gynecology: Hospital of the University of Pennsylvania

  • Chief Resident

    Medical School: Columbia University College of Physicians and Surgeons
    Doctor of Philosophy (PhD):
    Cornell University of Graduate School of Medical Sciences

    • Cell Biology and Genetics

    Education: Princeton University: Bachelor of Science in Biology and Biochemistry


    Memorial Sloan Kettering Cancer Center: Department of Surgery: 1997-2006; Director of Translational Research 2005-2006


    • American Board of Obstetrics & Gynecology: Diplomate of Obstetrics & Gynecology
    • American Board of Obstetrics & Gynecology: Diplomate of Genecologic Oncology


    Gynecologic Oncologist: New York City: http://www.drelizabethpoynor.com/




    • New York Medical Women’s Association
    • American Medical Women’s Association
    • American Medical Association
    • Medical Society State of New York
    • New York County Medical Society
    • Society of Gynecologic Oncologists
    • Society of Memorial Gynecologic Oncologists
    • Metropolitan Gynecologic Oncology Society
    • American Society Clinical Oncologists
    • Fellow, American College of Obstetricians and Gynecologists
    • North American Menopause Society
    • Society of Laparoendoscopic Surgeons
    • American Association of Gynecologic Laparscopists


    Cornell Graduate School of Medical Sciences                                1998-2004
    Sloan Kettering Institute
    Principal Investigator
    Extensive work with the genetics and molecular biology of ovarian cancer, including gene expression microarray analysis.

    Memorial Sloan-Kettering Cancer Center                                      2004-2006
    Principal Investigator
    Defining the role of the angiogenic response in tumor sensitivity to ionizing radiation.





    Memorial Sloan-Kettering Cancer Center

    2003-2004      A Phase I, Open-Label, Multicenter Study to Evaluate the Effect of Tumor-Based Her2 Activation on the Efficacy of Rhumab 2C4 (pertuzumab) in Subjects with Advanced, Refractory, Or Recurrent Ovarian Cancer (toc2689g) Co-principal investigator



    2003-2006      A Phase II Study of Cetuximab (c225)/paclitaxel/Carboplatin for the Initial Treatment of Advanced Stage Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Co-investigator


    2001-2002      Phase I Trial of Ps-341 (nsc 681239) and Carboplatin in Recurrent Or Progressive Epithelial Ovarian Cancer or Primary Peritoneal Cancer, Or Fallopian Tube Cancer Co-investigator

    2002-2004       Phase I Trial of the Monoclonal Anti-Idiotype Antibody Aca125 in Patients with Epithelial Ovarian, Fallopian Tube, Or Peritoneal Cancer Co-principal investigator


    2002-2006       Postoperative Recovery in Patients Receiving Patient-Controlled Epidural Analgesia (pcea) Compared to Patient-Controlled Intravenous Analgesia (pca) after Major Open Gynecologic Surgery: A Randomized Controlled Trial Co-investigator